Journal
CHEMISTRY & BIOLOGY
Volume 18, Issue 1, Pages 90-100Publisher
CELL PRESS
DOI: 10.1016/j.chembiol.2010.11.010
Keywords
-
Categories
Funding
- Fundacao para a Ciencia e Tecnologia
- Medinfar Pharmaceuticals SA [SFRH/BDE/15559/2005]
- Centre for Environmental and Marine Studies (CESAM) of University of Aveiro
- DFG
- Fundação para a Ciência e a Tecnologia [SFRH/BDE/15559/2005] Funding Source: FCT
Ask authors/readers for more resources
Lichenicidin is a class II two-component lantibiotic produced by Bacillus licheniformis. It is composed of the two peptides Bli alpha and Bli beta, which act synergistically against various Gram-positive bacteria. The lichenicidin gene cluster was successfully expressed in Escherichia coli, thus constituting the first report to our knowledge of a full reconstitution of a lantibiotic biosynthetic pathway in vivo by a Gram-negative host. This system was further exploited to characterize and assign the function of proteins encoded in the biosynthetic gene cluster in the maturation of lichenicidin peptides. Moreover, a trans complementation system was developed for expression of Blia and Blip variants in vivo. This contribution will spur future studies in the heterologous expression and engineering of lantibiotics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available